These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 11409107)

  • 1. Biotechnology. Bubble, bubble, toil and trouble.
    Boorstin J
    Fortune; 2001 Jun; 143(12):48. PubMed ID: 11409107
    [No Abstract]   [Full Text] [Related]  

  • 2. The biotechnology bubble machine.
    Rasnick D
    Nat Biotechnol; 2003 Apr; 21(4):355-6. PubMed ID: 12665813
    [No Abstract]   [Full Text] [Related]  

  • 3. Diversa restructures, raising question over bioprospecting.
    Sheridan C
    Nat Biotechnol; 2006 Mar; 24(3):229. PubMed ID: 16525364
    [No Abstract]   [Full Text] [Related]  

  • 4. Will investors return to biotechnology?
    Dorey E
    Nat Biotechnol; 1999 Feb; 17(2):128. PubMed ID: 10052340
    [No Abstract]   [Full Text] [Related]  

  • 5. Biotech bonanza.
    Stipp D
    Fortune; 1999 Nov; 140(9):333-4. PubMed ID: 10623111
    [No Abstract]   [Full Text] [Related]  

  • 6. Public biotechnology 2001--the numbers.
    Lähteenmäki R; Fletcher L
    Nat Biotechnol; 2002 Jun; 20(6):551-5. PubMed ID: 12042853
    [No Abstract]   [Full Text] [Related]  

  • 7. Biotechnology soared and fell in a roller-coaster 12 months.
    Gershon D
    Nature; 1992 Nov; 360(6401):200. PubMed ID: 1436101
    [No Abstract]   [Full Text] [Related]  

  • 8. Shutters come off IPO window.
    Hodgson J
    Nat Biotechnol; 2002 Jan; 20(1):6. PubMed ID: 11753342
    [No Abstract]   [Full Text] [Related]  

  • 9. The rise of venture capital and biotechnology in the US and Europe.
    Lee DP; Dibner MD
    Nat Biotechnol; 2005 Jun; 23(6):672-6. PubMed ID: 15940233
    [No Abstract]   [Full Text] [Related]  

  • 10. Where the money is.
    Fitzgerald M
    Nat Biotechnol; 2006 Mar; 24(3):240-2. PubMed ID: 16525370
    [No Abstract]   [Full Text] [Related]  

  • 11. Spinning the wheel on ImClone.
    Varchaver N
    Fortune; 2003 Apr; 147(8):123-5. PubMed ID: 12728651
    [No Abstract]   [Full Text] [Related]  

  • 12. Realizing potential: the state of Asian bioentrepreneurship.
    Tang CM; Mahmud MA; Foo FK; Chu SY; Chiu RI; Tanticharoen M; Zhang L; Chang TW
    Nat Biotechnol; 2003 Jul; 21 Suppl():BE15-22. PubMed ID: 12874972
    [No Abstract]   [Full Text] [Related]  

  • 13. Sumitomo buys Oxford finance.
    Bouchie A
    Nat Biotechnol; 2004 Apr; 22(4):480. PubMed ID: 15085808
    [No Abstract]   [Full Text] [Related]  

  • 14. Pension plans dally with biotech.
    Ransom J
    Nat Biotechnol; 2006 Jun; 24(6):600. PubMed ID: 16763575
    [No Abstract]   [Full Text] [Related]  

  • 15. Public biotechnology 2002--the numbers.
    Lähteenmäki R; DeFrancesco L
    Nat Biotechnol; 2003 Jun; 21(6):607-12. PubMed ID: 12776143
    [No Abstract]   [Full Text] [Related]  

  • 16. Cautious exuberance after the first quarter.
    Howard K
    Nat Biotechnol; 2004 May; 22(5):491-2. PubMed ID: 15122272
    [No Abstract]   [Full Text] [Related]  

  • 17. Enthusiasm cools in Q2.
    Lawrence S
    Nat Biotechnol; 2005 Aug; 23(8):914. PubMed ID: 16082352
    [No Abstract]   [Full Text] [Related]  

  • 18. When less is more.
    Booth BL
    Nat Biotechnol; 2007 Aug; 25(8):853-7. PubMed ID: 17687357
    [No Abstract]   [Full Text] [Related]  

  • 19. Healthcare stocks soar on wings of restructuring.
    Lutz S
    Mod Healthc; 1996 Jan; 26(2):3. PubMed ID: 10153952
    [No Abstract]   [Full Text] [Related]  

  • 20. The YIC factor.
    Nat Biotechnol; 2005 Oct; 23(10):1187. PubMed ID: 16211041
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.